Header Logo

Connection

John Somberg to Female

Back to Details
This is a "connection" page, showing publications John Somberg has written about Female.
John Somberg
Connection Strength
0.799
Female
  1. Retrospective Evaluation on the Analgesic Activities of 2 Compounded Topical Creams and Voltaren Gel in Chronic Noncancer Pain. Am J Ther. 2015 Sep-Oct; 22(5):342-9.
    View in: PubMed
    Score: 0.040
  2. Evaluation of the Effects of Different Energy Drinks and Coffee on Endothelial Function. Am J Cardiol. 2015 Nov 01; 116(9):1457-60.
    View in: PubMed
    Score: 0.040
  3. A Rapid Method to Evaluate Cardiac Repolarization Changes: The Effect of Two Coffee Strengths on the QT Interval. Cardiology. 2015; 131(3):203-8.
    View in: PubMed
    Score: 0.040
  4. Retrospective Study on the Analgesic Activity of a Topical (TT-CTAC) Cream in Patients With Diabetic Neuropathy and Other Chronic Pain Conditions. Am J Ther. 2015 May-Jun; 22(3):214-21.
    View in: PubMed
    Score: 0.040
  5. The Supremes got it right. Am J Ther. 2013 Jul-Aug; 20(4):315.
    View in: PubMed
    Score: 0.035
  6. Gender differences in cardiac repolarization following intravenous sotalol administration. J Cardiovasc Pharmacol Ther. 2012 Mar; 17(1):86-92.
    View in: PubMed
    Score: 0.030
  7. Developing a safe intravenous sotalol dosing regimen. Am J Ther. 2010 Jul-Aug; 17(4):365-72.
    View in: PubMed
    Score: 0.028
  8. The effects of chiral isolates of methadone on the cardiac potassium channel IKr. Cardiology. 2009; 113(1):59-65.
    View in: PubMed
    Score: 0.025
  9. Incidence and predictors of screen failures due to positive urine tests for alcohol, drugs of abuse, and cotinine among normal healthy research volunteers (NHRVs): analysis of data from 687 NHRVs screened at a large clinical pharmacology unit in the United States. Am J Ther. 2008 May-Jun; 15(3):214-20.
    View in: PubMed
    Score: 0.024
  10. Flecainide: safety and efficacy. Cardiology. 2008; 111(2):82.
    View in: PubMed
    Score: 0.024
  11. The additive effects of the active component of grapefruit juice (naringenin) and antiarrhythmic drugs on HERG inhibition. Cardiology. 2008; 110(3):145-52.
    View in: PubMed
    Score: 0.024
  12. Extracellular acidification and hyperkalemia induce changes in HERG inhibition by ibutilide. Cardiology. 2008; 110(3):209-16.
    View in: PubMed
    Score: 0.024
  13. The effects of quinidine and its chiral isolates on erg-1sm potassium current and correlation with gastrointestinal augmentation. Am J Ther. 2007 May-Jun; 14(3):269-76.
    View in: PubMed
    Score: 0.023
  14. The effect of high extracellular potassium on IKr inhibition by anti-arrhythmic agents. Cardiology. 2007; 108(1):18-27.
    View in: PubMed
    Score: 0.022
  15. Evaluation of a 12-lead digital Holter system for 24-hour QT interval assessment. Cardiology. 2006; 106(4):224-32.
    View in: PubMed
    Score: 0.021
  16. A mechanism for the potential proarrhythmic effect of acidosis, bradycardia, and hypokalemia on the blockade of human ether-a-go-go-related gene (HERG) channels. Am J Ther. 2005 Jul-Aug; 12(4):328-36.
    View in: PubMed
    Score: 0.020
  17. The pharmacologic treatment of heart failure. Am J Ther. 2004 Nov-Dec; 11(6):480-8.
    View in: PubMed
    Score: 0.019
  18. Comparative effects of rapid bolus administration of aqueous amiodarone versus 10-minute cordarone I.v. infusion on mean arterial blood pressure in conscious dogs. Cardiovasc Drugs Ther. 2004 Sep; 18(5):345-51.
    View in: PubMed
    Score: 0.019
  19. Lack of a hypotensive effect with rapid administration of a new aqueous formulation of intravenous amiodarone. Am J Cardiol. 2004 Mar 01; 93(5):576-81.
    View in: PubMed
    Score: 0.018
  20. Enhancement of myocardial vulnerability by atrial fibrillation. Am J Ther. 2004 Jan-Feb; 11(1):33-43.
    View in: PubMed
    Score: 0.018
  21. A case of herceptin cardiotoxicity. Am J Ther. 2004 Jan-Feb; 11(1):74-6.
    View in: PubMed
    Score: 0.018
  22. The quest for an aqueous amiodarone. Am J Ther. 2003 Nov-Dec; 10(6):458-61.
    View in: PubMed
    Score: 0.018
  23. Influence of electrolyte abnormalities on interlead variability of ventricular repolarization times in 12-lead electrocardiography. Am J Ther. 2001 Mar-Apr; 8(2):117-22.
    View in: PubMed
    Score: 0.015
  24. Neurocardiogenic syncope with Addison's disease. Am J Ther. 2000 Sep; 7(5):328-31.
    View in: PubMed
    Score: 0.014
  25. Effect of intracoronary balloon inflation at percutaneous transluminal coronary angioplasty on QT dispersion. Am Heart J. 1998 Mar; 135(3):519-22.
    View in: PubMed
    Score: 0.012
  26. Prostaglandin E1 : electrophysiological safety in patients with congestive heart failure and peripheral arterial occlusive disease. The Alprostadil Investigators. Am J Ther. 1997 Nov-Dec; 4(11-12):401-4.
    View in: PubMed
    Score: 0.012
  27. QT interval dispersion in healthy subjects and survivors of sudden cardiac death: circadian variation in a twenty-four-hour assessment. Am J Cardiol. 1997 May 01; 79(9):1190-3.
    View in: PubMed
    Score: 0.011
  28. Relation of left ventricular mass and QT dispersion in patients with systematic hypertension. Am J Cardiol. 1997 Feb 15; 79(4):508-11.
    View in: PubMed
    Score: 0.011
  29. A randomized comparative study of the electrophysiological and electrocardiographic effects of isradipine vs verapamil. Acta Anaesthesiol Scand Suppl. 1993; 99:43-7.
    View in: PubMed
    Score: 0.008
  30. The antiarrhythmic effects of d-sotalol. Am Heart J. 1987 Sep; 114(3):539-44.
    View in: PubMed
    Score: 0.006
  31. Evaluation of dosing interval and optimum dose of cibenzoline. J Clin Pharmacol. 1987 Sep; 27(9):666-72.
    View in: PubMed
    Score: 0.006
  32. Chronic flecainide therapy selected by electrophysiology testing of intravenous flecainide. Am Heart J. 1987 Jul; 114(1 Pt 1):18-25.
    View in: PubMed
    Score: 0.006
  33. Comparative efficacy of pirmenol and procainamide in a drug-resistant population with ventricular tachycardia. J Clin Pharmacol. 1987 Jul; 27(7):481-6.
    View in: PubMed
    Score: 0.006
  34. Antiarrhythmic efficacy of ethmozine in patients with ventricular tachycardia as determined by programmed electrical stimulation. Am Heart J. 1986 Apr; 111(4):661-6.
    View in: PubMed
    Score: 0.005
  35. Antiarrhythmic drug efficacy at electrophysiology testing: predictive effectiveness of procainamide and flecainide. Am Heart J. 1986 Apr; 111(4):632-8.
    View in: PubMed
    Score: 0.005
  36. Lorcainide therapy in a cardiac arrest population. Am Heart J. 1986 Apr; 111(4):648-53.
    View in: PubMed
    Score: 0.005
  37. Prophylactic tocainide or lidocaine in acute myocardial infarction. Am J Cardiol. 1986 Mar 01; 57(8):527-31.
    View in: PubMed
    Score: 0.005
  38. QT prolongation and the antiarrhythmic efficacy of amiodarone. J Am Coll Cardiol. 1986 Jan; 7(1):142-7.
    View in: PubMed
    Score: 0.005
  39. Electrophysiologic evaluation of the antiarrhythmic effects of N-acetylprocainamide for ventricular tachycardia secondary to coronary artery disease. Am J Cardiol. 1985 Nov 15; 56(13):877-81.
    View in: PubMed
    Score: 0.005
  40. The clinical significance of polymorphic ventricular tachycardia provoked at electrophysiologic testing. Am Heart J. 1985 Jul; 110(1 Pt 1):17-24.
    View in: PubMed
    Score: 0.005
  41. The arrhythmogenicity of antiarrhythmic agents. Am Heart J. 1985 May; 109(5 Pt 1):1090-7.
    View in: PubMed
    Score: 0.005
  42. Antiarrhythmic effects of cibenzoline. Am Heart J. 1985 Apr; 109(4):827-33.
    View in: PubMed
    Score: 0.005
  43. Therapy for late post infarction ventricular tachycardia. Angiology. 1985 Mar; 36(3):181-90.
    View in: PubMed
    Score: 0.005
  44. Prolongation of QT interval and antiarrhythmic action of bepridil. Am Heart J. 1985 Jan; 109(1):19-27.
    View in: PubMed
    Score: 0.005
  45. Long term lorcainide therapy guided by electrophysiology studies. Acta Cardiol. 1985; 40(6):621-36.
    View in: PubMed
    Score: 0.005
  46. Flecainide: long-term treatment using a reduced dosing schedule. Am J Cardiol. 1985 Jan 01; 55(1):79-83.
    View in: PubMed
    Score: 0.005
  47. The effect of bepridil, verapamil, and quinidine in the prevention of ventricular tachycardia induced by programmed electrical stimulation in the digitalized dog. Am Heart J. 1984 Nov; 108(5):1236-43.
    View in: PubMed
    Score: 0.005
  48. Lorcainide therapy for the high-risk patient post myocardial infarction. Am J Cardiol. 1984 Aug 13; 54(4):37B-42B.
    View in: PubMed
    Score: 0.005
  49. Evaluation of lorcainide in patients with symptomatic ventricular tachycardia. Am J Cardiol. 1984 Aug 13; 54(4):43B-48B.
    View in: PubMed
    Score: 0.005
  50. Comparison of noninvasive arrhythmia induction techniques with electrophysiologic studies and evaluation of lorcainide in patients with symptomatic ventricular tachycardia. Am J Cardiol. 1984 Aug 13; 54(4):49B-54B.
    View in: PubMed
    Score: 0.005
  51. Antiarrhythmic action of bethanidine. Am J Cardiol. 1984 Aug 01; 54(3):343-6.
    View in: PubMed
    Score: 0.005
  52. Pacing termination of ventricular tachycardia: influence of antiarrhythmic-slowed ectopic rate. Am Heart J. 1984 Apr; 107(4):638-43.
    View in: PubMed
    Score: 0.005
  53. Effect of quinidine on differing sensitivities of Purkinje fibers and myocardium to inhibition of monovalent cation transport by digitalis in dogs. Am J Cardiol. 1983 Nov 01; 52(8):1123-6.
    View in: PubMed
    Score: 0.004
  54. Histamine antagonists as antiarrhythmic agents in ouabain cardiotoxicity in the cat. J Pharmacol Exp Ther. 1980 Aug; 214(2):375-80.
    View in: PubMed
    Score: 0.004
  55. Hypercalcemia, arrhythmia, and mood stabilizers. J Clin Psychopharmacol. 2000 Apr; 20(2):260-4.
    View in: PubMed
    Score: 0.003
  56. The antiarrhythmic effects of quinidine and propranolol in the ouabain-intoxicated spinally transected cat. Eur J Pharmacol. 1979 Feb 15; 54(1-2):161-6.
    View in: PubMed
    Score: 0.003
  57. KCNE1 mutations cause jervell and Lange-Nielsen syndrome. Nat Genet. 1997 Nov; 17(3):267-8.
    View in: PubMed
    Score: 0.003
  58. Electrophysiology of Ethmozine (moricizine HCl) for ventricular tachycardia. Am J Cardiol. 1987 Oct 16; 60(11):67F-72F.
    View in: PubMed
    Score: 0.001
  59. Safety and efficacy of flestolol, a new ultrashort-acting beta-adrenergic blocking agent, for supraventricular tachyarrhythmias. Am J Cardiol. 1986 Nov 01; 58(10):1005-8.
    View in: PubMed
    Score: 0.001
  60. Multicenter trial of sotalol for suppression of frequent, complex ventricular arrhythmias: a double-blind, randomized, placebo-controlled evaluation of two doses. J Am Coll Cardiol. 1986 Oct; 8(4):752-62.
    View in: PubMed
    Score: 0.001
  61. Comparative study of encainide and quinidine in the treatment of ventricular arrhythmias. J Am Coll Cardiol. 1986 Jan; 7(1):9-16.
    View in: PubMed
    Score: 0.001
  62. Pharmacokinetics of oral cibenzoline in arrhythmia patients. Clin Pharmacokinet. 1985 Mar-Apr; 10(2):178-86.
    View in: PubMed
    Score: 0.001
  63. Cibenzoline plasma concentration and antiarrhythmic effect. Clin Pharmacol Ther. 1984 Mar; 35(3):307-16.
    View in: PubMed
    Score: 0.001
  64. The effect of altered renal perfusion pressure on clearance of digoxin. Circulation. 1980 Mar; 61(3):521-5.
    View in: PubMed
    Score: 0.001
  65. Refractory heart failure. Comparison of time course of action of sublingual nitroglycerin and isosorbide dinitrate, oral or sublingual. N Y State J Med. 1978 May; 78(6):888-9.
    View in: PubMed
    Score: 0.001
  66. The influence of spinal cord transection on the capacity of digitoxin to induce cardiotoxicity. Arch Int Pharmacodyn Ther. 1974 Feb; 207(2):340-7.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.